Contact
 

The U.S. Military HIV Research Program (MHRP) issued a statement on the one-year anniversary of the announcement of the results of RV144, the trial in Thailand that showed the first evidence that a vaccine is able to reduce risk of HIV...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), will host a public meeting on Tuesday, October 26, 2010 from 8:00 a.m. to 5:30 p.m.

The CHVI launched a consultation on the CHVI Research & Development Alliance.  To provide input (through  5...

AVAC released a statement welcoming the new Global HIV Vaccine Enterprise Scientific Strategic Plan stating that the Plan is "a critical document that the field must implement as part of ongoing efforts to improve coordination,...

MedPage Today reported that HIV vaccine researchers are calling for more and better human trials as part of the search for a way to prevent transmission of the virus.  The full story is available...

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account